Related references
Note: Only part of the references are listed.Hepatic Transport of 25-Hydroxyvitamin D3 Conjugates: A Mechanism of 25-Hydroxyvitamin D3 Delivery to the Intestinal Tract
Chunying Gao et al.
DRUG METABOLISM AND DISPOSITION (2018)
Vitamin D and tyrosine kinase inhibitors in chronic myeloid leukemia
Leonardo Campiotti et al.
INTERNAL AND EMERGENCY MEDICINE (2018)
Vitamin D in hematological disorders and malignancies
Paige M. Kulling et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2017)
Adverse effects of imatinib in children with chronic myelogenous leukemia
Worawut Choeyprasert et al.
PEDIATRICS INTERNATIONAL (2017)
Vitamin D and Cancer Risk and Mortality: State of the Science, Gaps, and Challenges
Alison M Mondul et al.
EPIDEMIOLOGIC REVIEWS (2017)
PharmGKB summary: sorafenib pathways
Li Gong et al.
PHARMACOGENETICS AND GENOMICS (2017)
Low serum vitamin D levels are associated with shorter survival after first-line azacitidine treatment in patients with myelodysplastic syndrome and secondary oligoblastic acute myeloid leukemia
Aleksandar Radujkovic et al.
CLINICAL NUTRITION (2017)
Impact of Membrane Drug Transporters on Resistance to Small-Molecule Tyrosine Kinase Inhibitors
Claudia Neul et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2016)
Serum 25-Hydroxyvitamin D Levels and Prognosis in Hematological Malignancies: A Systematic Review and Meta-Analysis
Wei Wang et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2015)
Vitamin D Analogs Potentiate the Antitumor Effect of Imatinib Mesylate in a Human A549 Lung Tumor Model
Ewa Maj et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2015)
Inhibitory effects of imatinib on vitamin D3 synthesis in human keratinocytes
Lysann Michaela Mehlig et al.
MOLECULAR MEDICINE REPORTS (2015)
Low 25(OH) Vitamin D3 Levels Are Associated With Adverse Outcome in Newly Diagnosed, Intensively Treated Adult Acute Myeloid Leukemia
Hun Ju Lee et al.
CANCER (2014)
Vitamin D Metabolism, Mechanism of Action, and Clinical Applications
Daniel D. Bikle
CHEMISTRY & BIOLOGY (2014)
Serum 25-hydroxyvitamin D levels in relation to disease status and prognosis in acute myeloid leukemia
Tahani A. Elkerdany et al.
EGYPTIAN JOURNAL OF HAEMATOLOGY (2014)
Plasma 25-hydroxyvitamin D concentration and lymphoma risk: results of the European Prospective Investigation into Cancer and Nutrition
Anna Luczynska et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2013)
European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013
Michele Baccarani et al.
BLOOD (2013)
Growth failure in children with chronic myeloid leukemia receiving imatinib is due to disruption of GH/IGF-1 axis
Karthik R. Narayanan et al.
PEDIATRIC BLOOD & CANCER (2013)
Changes in bone metabolic parameters in children with chronic myeloid leukemia on imatinib treatment
Bernadette Anna Sophia Jaeger et al.
MEDICAL SCIENCE MONITOR (2012)
Serum 25-hydroxyvitamin D levels are associated with prognosis in hematological malignancies
Xavier Thomas et al.
HEMATOLOGY (2011)
Evaluation, Treatment, and Prevention of Vitamin D Deficiency: an Endocrine Society Clinical Practice Guideline
Michael F. Holick et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
Distinct Impact of Imatinib on Growth at Prepubertal and Pubertal Ages of Children with Chronic Myeloid Leukemia
Haruko Shima et al.
JOURNAL OF PEDIATRICS (2011)
Chemotherapy is linked to severe vitamin D deficiency in patients with colorectal cancer
Marwan G. Fakih et al.
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE (2009)
Up-Regulation of Transporters and Enzymes by the Vitamin D Receptor Ligands, 1α,25-Dihydroxyvitamin D3 and Vitamin D Analogs, in the Caco-2 Cell Monolayer
Jianghong Fan et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2009)
Interaction of imatinib with human organic ion carriers
Shuiying Hu et al.
CLINICAL CANCER RESEARCH (2008)
Prospective study of serum vitamin D and cancer mortality in the United States
D. Michal Freedman et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2007)
Circulating 25-hydroxyvitamin D levels predict survival in early-stage non-small-cell lung cancer patients
Wei Zhou et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Vitamin D signalling pathways in cancer: potential for anticancer therapeutics
Kristin K. Deeb et al.
NATURE REVIEWS CANCER (2007)
Prospective study of predictors of vitamin D status and cancer incidence and mortality in men
E Giovannucci et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)
The role of vitamin D in cancer prevention
CF Garland et al.
AMERICAN JOURNAL OF PUBLIC HEALTH (2006)
Vitamin D3 from sunlight may improve the prognosis of breast-, colon- and prostate cancer (Norway)
TE Robsahm et al.
CANCER CAUSES & CONTROL (2004)
Active transport of imatinib into and out of cells: implications for drug resistance
J Thomas et al.
BLOOD (2004)
Iα,25-dihydroxyvitamin D3 (calcitriol) and its analogue, 19-nor-Iα,25(OH)2D2, potentiate the effects of ionising radiation on human prostate cancer cells
N Dunlap et al.
BRITISH JOURNAL OF CANCER (2003)
Prostate cancer risk and prediagnostic serum 25-hydroxyvitamin D levels (Finland)
MH Ahonen et al.
CANCER CAUSES & CONTROL (2000)
Share Paper
